Viewing Opinion | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

2016-04-01

Opinion for Concordia Healthcare (CXR-T)

Signal Price Bias Subject Owned
COMMENT $33.100 UNKNOWN CANADIAN & ETF's Unknown

Has been caught up in the Valeant (VRX-T) downdraft. However, it is starting to look very interesting from a value proposition. If the earnings can be believed, it is less than 4X earnings, but they have a lot of debt. While it looks cheap on a Price/Book basis, the debt worries him. It might be a short-term buy, but for the long-term you have to really worry about the debt.

Allan Meyer
VP & Portfolio Manager, Wickham Investment Counsel

No Comments.


You must be logged in to comment.